These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8838932

  • 21. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S, Kim BJ, Lee YB, Lee WS.
    JAMA Dermatol; 2018 Oct 01; 154(10):1145-1151. PubMed ID: 30073292
    [Abstract] [Full Text] [Related]

  • 22. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K, Fukushima S, Mizuhashi S, Jinnin M, Makino T, Inoue Y, Ihn H.
    Allergol Int; 2020 Apr 01; 69(2):274-278. PubMed ID: 31767273
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C, Gupta S, Kanwar AJ.
    J Drugs Dermatol; 2006 Mar 01; 5(3):262-6. PubMed ID: 16573260
    [Abstract] [Full Text] [Related]

  • 24. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y, Hatamochi A, Hamasaki Y, Suzuki H, Ikeda H, Yamazaki S.
    J Dermatol; 2008 Mar 01; 35(3):151-3. PubMed ID: 18346258
    [Abstract] [Full Text] [Related]

  • 25. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A, Mato F, Quiñones PA.
    Med Cutan Ibero Lat Am; 1984 Mar 01; 12(3):273-8. PubMed ID: 6384701
    [Abstract] [Full Text] [Related]

  • 26. Pulsed administration of corticosteroids in the treatment of alopecia areata.
    Sharma VK.
    Int J Dermatol; 1996 Feb 01; 35(2):133-6. PubMed ID: 8850047
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK, Shupack JL, Vafai JJ, Washenik K.
    J Am Acad Dermatol; 1998 Nov 01; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
    Nasca MR, Micali G, Pulvirenti N, Licastro Cicero R.
    Eur J Dermatol; 1998 Mar 01; 8(2):125-6. PubMed ID: 9649675
    [Abstract] [Full Text] [Related]

  • 35. Side-effects during treatment with SADBE.
    Frattasio A, Germino M, Cargnello S, Patrone P.
    Contact Dermatitis; 1997 Feb 01; 36(2):118-9. PubMed ID: 9062760
    [No Abstract] [Full Text] [Related]

  • 36. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L, Skopit S.
    J Drugs Dermatol; 2018 Aug 01; 17(8):914-917. PubMed ID: 30124734
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
    Valsecchi R, Cainelli T.
    Contact Dermatitis; 1985 Apr 01; 12(4):234. PubMed ID: 4017578
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND, Bunata K, Hebert AA.
    Clin Dermatol; 2015 Apr 01; 33(3):300-4. PubMed ID: 25889130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.